ICI | Cancer World Archive

With ICIs, the effect of mutations changes with cancer types

News 17 January 2019 0

“Immune checkpoint inhibitor (ICI) treatments benefit some patients with metastatic cancers, but predictive biomarkers are needed”: starting from this premise, a group of researchers of the Memorial Sloan Kettering Cancer Center in New York led [more]

Fatal reactions to immunotherapies are rare, but have diverse causes

News 24 September 2018 0

The most commonly prescribed class of immunotherapies (called ICIs, immune checkpoint inhibitors) are not free from fulminant and fatal toxic side effects; the researchers of the Vanderbilt-Ingram Cancer Center recently evaluated their toxicities, publishing the [more]